跳至主要内容
临床试验/IRCT201207267618N2
IRCT201207267618N2已完成3 期

Comparison of the efficacy of Rosa damascena extract and mefenamic acid on the severity of the primary dysmenorrhea pain: A double – blind randomized controlled trial

Research deputy of Tabriz University of Medical Sience0 个研究点目标入组 92 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 30 years(—)
性别
Female

入选标准

  • women with abdominal pain compatible with dysmenorrhea; being single; signing the informed consent sheet.
  • Exclusion criteria: pain severity more than 8 or less than 5 according to visual analogue scale system; history of genitourinary disease or abdomino-pelvic surgery; stressful event(loss); lack of compliancy; history of hypersensitivity to mefenamic acid; using drugs that interact with mefenamic acid.

排除标准

  • 未提供

研究者

发起方
Research deputy of Tabriz University of Medical Sience

相似试验